The following article has been retrieved from the archive and no longer contains the original video.
An investigation into pharmaceutical companies conducted by the European Commission has followed up a preliminary report made public last November warning them not to use anti-competitive practices.
Some drugmakers are suspected of arranging with generics producers to hold back cheap medicines in deals that cost healthcare providers billions of euros.
Delays in bringing less expensive generic drugs to the market pushed up consumers’ bills by 20 percent between 2000 and 2007, Brussels says.
A drug industry body welcomed the latest report, saying it shed light on regulatory barriers hindering the industry.
Copyright © 2009 euronews
tags: Drugs, Health, pharmaceutical companies
Top Stories & Breaking News


Chinese perceptions of Europe
EU shortens its phone number
EU gaining appreciation in Washington
EU to choose executive commission
Congratulations pour in for new EU president
Pro-Europe Ashton gets to sit at EU high-table
Why Ashton is EU Foreign Policy Chief
Why Van Rompuy is EU President
Anna Lindh journalism prize in Monaco
Citizens’ initiative, fleshing out the Lisbon… 








